What is the best pharmacologic treatment for sickle cell disease pain crises? (يفتح نافذة جديدة)

Baker M, Hafner JW.

Source‎: Ann Emerg Med 2012;59(6):515-6.

مفهرسة‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (يفتح نافذة جديدة)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (يفتح نافذة جديدة)

Frei-Jones MJ, Field JJ, DeBaun MR.

Source‎: Pediatr Blood Cancer 2009;53(3):401-5.

مفهرسة‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (يفتح نافذة جديدة)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (يفتح نافذة جديدة)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Source‎: Thromb Haemost 2007;98(2):392-6.

مفهرسة‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (يفتح نافذة جديدة)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (يفتح نافذة جديدة)

Okomo U, Meremikwu MM.

Source‎: Cochrane Database Syst Rev 2012;(6):CD005406.

مفهرسة‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (يفتح نافذة جديدة)

Guidelines for the management of the acute painful crisis in sickle cell disease. (يفتح نافذة جديدة)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Source‎: Br J Haematol 2003;120(5):744-52.

مفهرسة‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (يفتح نافذة جديدة)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (يفتح نافذة جديدة)

Ahmad FA, Macias CG, Allen JY.

Source‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

مفهرسة‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (يفتح نافذة جديدة)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (يفتح نافذة جديدة)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Source‎: Hemoglobin 2004;28(2):85-102.

مفهرسة‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (يفتح نافذة جديدة)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (يفتح نافذة جديدة)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Source‎: Blood 1998;92(9):3082-9.

مفهرسة‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (يفتح نافذة جديدة)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (يفتح نافذة جديدة)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Source‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

مفهرسة‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (يفتح نافذة جديدة)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (يفتح نافذة جديدة)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Source‎: Haematologica 2013;98(9):1375-82.

مفهرسة‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (يفتح نافذة جديدة)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (يفتح نافذة جديدة)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Source‎: JAMA 2003;289(9):1136-42.

مفهرسة‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (يفتح نافذة جديدة)

Predictors of bacteremia in febrile children with sickle cell disease. (يفتح نافذة جديدة)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Source‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

مفهرسة‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (يفتح نافذة جديدة)